Maturation and Diversity of the VRC01-Antibody Lineage over 15 Years of Chronic HIV-1 Infection. - Wikidata - wikimedia - TriplyDB

Maturation and Diversity of the VRC01-Antibody Lineage over 15 Years of Chronic HIV-1 Infection.

Maturation and Diversity of the VRC01-Antibody Lineage over 15 Years of Chronic HIV-1 Infection.

http://www.wikidata.org/entity/Q36444787

about

Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors Optimization of the Solubility of HIV-1-Neutralizing Antibody 10E8 through Somatic Variation and Structure-Based Design High-Throughput Sequencing-Based Immune Repertoire Study during Infectious Disease Broadly Neutralizing Antibodies for HIV Eradication A Little Help From the Follicles: Understanding the Germinal Center Response to Human Immunodeficiency Virus 1 Infection and Prophylactic Vaccines.Humanized Immunoglobulin Mice: Models for HIV Vaccine Testing and Studying the Broadly Neutralizing Antibody Problem.Influenza immunization elicits antibodies specific for an egg-adapted vaccine strain Free Energy Perturbation Calculation of Relative Binding Free Energy between Broadly Neutralizing Antibodies and the gp120 Glycoprotein of HIV-1.A Database of Human Immune Receptor Alleles Recovered from Population Sequencing Data.Gene-Specific Substitution Profiles Describe the Types and Frequencies of Amino Acid Changes during Antibody Somatic Hypermutation.Exceptional Antibodies Produced by Successive Immunizations.Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus Infection.Spatiotemporal hierarchy in antibody recognition against transmitted HIV-1 envelope glycoprotein during natural infection.Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C Infection.Effects of Darwinian Selection and Mutability on Rate of Broadly Neutralizing Antibody Evolution during HIV-1 Infection.Distinct germinal center selection at local sites shapes memory B cell response to viral escape Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design.Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin Mice.Likelihood-Based Inference of B Cell Clonal Families.Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting.Rhesus Macaque B-Cell Responses to an HIV-1 Trimer Vaccine Revealed by Unbiased Longitudinal Repertoire Analysis.Longitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies Immune-Selected HIV Variants.Antibodyomics: bioinformatics technologies for understanding B-cell immunity to HIV-1.Optimal Sequential Immunization Can Focus Antibody Responses against Diversity Loss and Distraction.HIV-1 VACCINES. Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen.New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional Potency Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice.Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop.Maturational characteristics of HIV-specific antibodies in viremic individuals Key gp120 Glycans Pose Roadblocks to the Rapid Development of VRC01-Class Antibodies in an HIV-1-Infected Chinese Donor Early Antibody Lineage Diversification and Independent Limb Maturation Lead to Broad HIV-1 Neutralization Targeting the Env High-Mannose Patch HIV-1 clade C escapes broadly neutralizing autologous antibodies with N332 glycan specificity by distinct mechanisms SONAR: A High-Throughput Pipeline for Inferring Antibody Ontogenies from Longitudinal Sequencing of B Cell Transcripts.Optimal immunization cocktails can promote induction of broadly neutralizing Abs against highly mutable pathogens.Progress toward active or passive HIV-1 vaccination.Differences in Allelic Frequency and CDRH3 Region Limit the Engagement of HIV Env Immunogens by Putative VRC01 Neutralizing Antibody Precursors.Ontogeny-based immunogens for the induction of V2-directed HIV broadly neutralizing antibodies.New approaches to HIV vaccine development.Panels of HIV-1 Subtype C Env Reference Strains for Standardized Neutralization Assessments.HIV-1 envelope glycoprotein immunogens to induce broadly neutralizing antibodies.

P2860

Q27643993-EE22B555-4F46-4608-9747-7F599A92BDE7 Q27644646-8DD90D3A-3628-4C65-8C6B-58F3F16E3B96 Q28068214-E7F85B16-60F5-451F-9E2A-F0EF3378A682 Q28073939-D0C98BA4-385C-4E4E-B0FB-E2A2B6DBC579 Q30234577-4635A3ED-4D56-4A9D-A596-04677E0CF9FE Q30234773-4082EAA1-617A-4663-A9DF-20C4CFE2B37A Q30395005-7A28F2B2-51EF-4F90-A9B7-1E8198BCB8C3 Q30395868-EF3A7789-646A-4375-8E50-A8CE7EC4150E Q31156257-D51E14C8-5568-4B4A-92CF-A7AA74C47408 Q33654599-BA76A6D3-84A7-40E7-8204-91163AC3C1F5 Q35862420-C8ED4971-AD6C-4AAB-9A88-DEF5B488F22E Q35914292-63D4AC78-3119-4BF0-A91E-42962DECEDD0 Q35925331-8D3AB94A-DEBC-4730-B475-B2285CF3E154 Q35974269-08187B06-9310-4A61-8020-68B5B0CB4AA1 Q36020766-9CFFC4F7-7DCE-49CE-9F99-1DB788BCB99F Q36080726-E40CE4EF-EA50-4FBE-B5DB-AD8AAECDFC01 Q36112751-F627132B-C8DC-4BE1-B4DA-B3A312E8D867 Q36159067-92138FE9-B602-483F-BB11-342C96AE352C Q36165278-58A2B907-C444-470F-A5AE-05D682876E71 Q36239578-9B3FFFBA-0D3A-4573-A271-11423127AE5A Q36245216-ED89A526-E688-40EB-AF2A-A6370BEE69ED Q36246646-AE10533A-38F2-473A-8C23-7E13126DB428 Q36263513-3A94611A-E881-486F-A3D3-673462769BC5 Q36263769-4EB363CE-392A-46E1-A199-1CD943016C7B Q36345558-0A6C8C33-9BC0-45BA-B468-926E3DCDD260 Q36433894-FBA0DEAC-300F-4A8D-AFF6-A537A3CF2ADE Q36627503-BD5D0DA7-BAAF-44EF-B9DB-542EC4C37322 Q36694111-9A7365C2-BEA7-41A8-AB15-FE975BD2B44A Q36862088-CC9FDD63-FA8D-46C6-BB4A-897A03414C72 Q36888400-E9C00C2C-1ECF-4B80-A043-E6EA38DC2336 Q37213491-6398976C-2A57-4A8D-9FA2-DCC17626767B Q37221386-FD2AC218-910A-4228-A14F-E67A21CE0C71 Q37271866-A6F438F0-8278-46C3-B0E6-99E73470A3FE Q37417794-3912CBB6-FC3C-4A8B-B6F7-003952A1B1AF Q37549777-45B8E8A1-95F9-45D9-AF8B-0C56C2E8A105 Q37551245-4CA9D599-E455-49E8-97BA-6A844BBC7FAC Q37634061-AB84E515-AC98-4251-828F-4646C2DB39CE Q38521826-9844E4F8-31AD-400B-8A26-6D02E0A4DDEA Q38659318-1294FDD8-4A89-41BB-98F9-C10514F7E2B4 Q38665463-371DDB21-4EE9-4995-9774-757BF6358775

P2860

Maturation and Diversity of the VRC01-Antibody Lineage over 15 Years of Chronic HIV-1 Infection.

http://www.wikidata.org/entity/Q36444787

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Maturation and Diversity of th ...... rs of Chronic HIV-1 Infection.

@ast

Maturation and Diversity of th ...... rs of Chronic HIV-1 Infection.

@en

type

label

Maturation and Diversity of th ...... rs of Chronic HIV-1 Infection.

@ast

Maturation and Diversity of th ...... rs of Chronic HIV-1 Infection.

@en

prefLabel

Maturation and Diversity of th ...... rs of Chronic HIV-1 Infection.

@ast

Maturation and Diversity of th ...... rs of Chronic HIV-1 Infection.

@en

P1433

Q36444787-EB463699-FA7E-4DC7-B341-5E2856ECD171

P1476

Q36444787-A9E282F8-5551-411B-9830-DD32752A95B7

P2093

Q36444787-01BE9D74-0A4A-4CDA-979E-527105AD7297

Q36444787-13B110C7-5684-43E5-8E29-6E59E6699F7E

Q36444787-295FABF7-1496-4801-85A5-D121EA9F7019

Q36444787-3578ADDA-9F73-45BC-9E97-188D11D5CF09

Q36444787-3612B7C8-286A-492D-8DB1-9C902500384A

Q36444787-42C07075-19AA-4AEF-A77E-6373C610F673

Q36444787-45C62CBF-474A-4863-BD76-CEABA826E9F2

Q36444787-4E79DA84-4B69-4859-83A4-5EA56EEBEECF

Q36444787-59210D12-C3FE-4E41-9BD3-B4BFC1059B4B

Q36444787-7FF2F585-CA58-4567-8B6E-04C6EC3A9597

P2860

Q36444787-0AE35C89-AE8F-4CF8-8E08-F19A04E4DB11

Q36444787-0C2C824B-C7D1-4517-86F9-CF89B4FCE5A8

Q36444787-0E9B1D57-7BE1-4D72-A8C8-BBCB42AF1C3A

Q36444787-19F16576-2661-4E72-8B14-4B099C69C2DB

Q36444787-1C9656B4-AE76-4B7D-92AA-866D378C952B

Q36444787-1D431931-D9AE-46BD-82D8-94D7A8E8F38F

Q36444787-1EA72CF1-4FDC-47AD-B047-DCE823DCCAD0

Q36444787-1EB5C98B-5B6F-48A9-9C9A-C13B18093BEB

Q36444787-20918719-1046-4B33-AE56-F17C44D568DC

Q36444787-20CDB28F-C452-4CCA-8A5C-A0BCD0A13DCC

P304

Q36444787-4DF913AD-F722-440A-8DE2-D3E6BCEB3ED0

P31

Q36444787-D16D2345-E5C8-43FF-A84B-0F1A4DCB2B3F

P356

Q36444787-3A345E5C-88DD-426A-9CD2-503445550CBD

P407

Q36444787-69D72D7B-22E1-4C5D-8F29-F3CD560A89F0

P433

Q36444787-12B74A1E-1087-4235-903E-62887C118EE5

P478

Q36444787-A0D4792B-C3C4-4752-A9B3-C786ED835CD0

P50

Q36444787-1C41A0A8-BF21-4B6B-B8F9-4C912CE004B9

Q36444787-50C3EF0C-1A06-4F44-B86E-24CCC97EBFEF

Q36444787-6C510038-48EC-4738-9CAB-F6E4AA053589

Q36444787-7C590F2F-6503-4234-B619-09FD5137916B

P577

Q36444787-E9A64A35-1BB8-4994-A646-3BE3F6ABF5A5

P5875

Q36444787-94BB6307-28C8-40C8-A288-3376D87546C8

P698

Q36444787-87B38244-D29E-456B-9FDC-6D5BAEDA6FFF

P921

Q36444787-6AE026D8-EB60-4E33-B1DF-44B7BBC30EDA

Q36444787-C9015A87-3A45-444C-95E9-D50A409EBA13

P932

Q36444787-73FB1BC9-76B5-41F8-9BB1-02467D6762C2

P356

J.CELL.2015.03.004

P1433

P1476

Maturation and Diversity of th ...... rs of Chronic HIV-1 Infection.

@en

P2093

Baoshan Zhang

http://www.w3.org/2001/XMLSchema#string

Chaim A Schramm

http://www.w3.org/2001/XMLSchema#string

Gwo-Yu Chuang

http://www.w3.org/2001/XMLSchema#string

Ivelin S Georgiev

http://www.w3.org/2001/XMLSchema#string

Kevin O Saunders

http://www.w3.org/2001/XMLSchema#string

Krisha McKee

http://www.w3.org/2001/XMLSchema#string

Lawrence Shapiro

http://www.w3.org/2001/XMLSchema#string

M Gordon Joyce

http://www.w3.org/2001/XMLSchema#string

Mark Connors

http://www.w3.org/2001/XMLSchema#string

Mark K Louder

http://www.w3.org/2001/XMLSchema#string

P2860

Antibody vs. HIV in a clash of evolutionary titans

Increasing the potency and breadth of an HIV antibody by using structure-based rational design

Structural definition of a conserved neutralization epitope on HIV-1 gp120

HIV-1 neutralizing antibodies: understanding nature's pathways

Antibody domain exchange is an immunological solution to carbohydrate cluster recognition

Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120

Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus

Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies

Structure and function of broadly reactive antibody PG16 reveal an H3 subdomain that mediates potent neutralization of HIV-1

Crystal Structure of PG16 and Chimeric Dissection with Somatically Related PG9: Structure-Function Analysis of Two Quaternary-Specific Antibodies That Effectively Neutralize HIV-1

P304

470-485

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CELL.2015.03.004

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

161

http://www.w3.org/2001/XMLSchema#string

P50

NISC Comparative Sequencing Program

James C Mullikin

P577

2015-04-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274901600

http://www.w3.org/2001/XMLSchema#string

P698

25865483

http://www.w3.org/2001/XMLSchema#string

P921

P932

4706178

http://www.w3.org/2001/XMLSchema#string